Erythropoietin Pathway: A Potential Target for the Treatment of Depression - sprookjes - yvandenbroek - TriplyDB

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

http://www.wikidata.org/entity/Q26750850

about

Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy Affective immunology: where emotions and the immune response converge.Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo Sciatic nerve regeneration by transplantation of Schwann cells via erythropoietin controlled-releasing polylactic acid/multiwalled carbon nanotubes/gelatin nanofibrils neural guidance conduit.Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis.Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.Erythropoietin Induces Homeostatic Plasticity at Hippocampal Synapses.Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia.Cerebrospinal fluid neuron specific enolase, interleukin-1β and erythropoietin concentrations in children after seizures.Signaling by Erythropoietin GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders Neuroprogression: the hidden mechanism of depression

P2860

Q28066377-1059FCDA-21B8-4B70-8C4B-12FF9BCB28D0 Q33721042-ACE436D4-FCB0-4B73-9B9C-25E95F8995E5 Q33765808-FD8FE468-5F29-4F41-B22B-8F72B66E4798 Q38694547-0262F3C0-167A-4C5A-B5C1-F1EEE37578CC Q40292313-66827F0F-1E43-4D6D-9501-96DD854D678C Q40953750-B0729FFC-1026-450F-A32E-7DBBCADA5757 Q41082884-7B9B230B-2A32-4AE4-91B0-5B5BF8B4769C Q47753078-4CEA4A11-82E0-4D5D-96DD-9A509F028AF2 Q50125639-018FD6F6-5AB2-427A-92BD-72ED98692D18 Q53479803-D99DED3D-109E-4836-AFA6-26ED61FF5C38 Q56861031-567C36A7-4FDD-4518-B9BA-C1AE9229195E Q57477426-A97C51F0-994D-46C8-8A76-813192EA952E Q58800774-69A3B808-AFF7-4DA7-815A-34497ACA3E2D Q59126066-6D22A83B-BA6D-4FC1-958E-F31EA7005123

P2860

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

http://www.wikidata.org/entity/Q26750850

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@ast

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@en

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@nl

type

label

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@ast

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@en

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@nl

prefLabel

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@ast

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@en

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@nl

P1433

Q26750850-B86202FA-2A55-448C-9DD1-09DDF880474E

P1476

Q26750850-79026FB7-B893-4027-95CA-DEEC0C7110BC

P2093

Q26750850-11E7EFC4-45D7-4013-98D1-37BF7D7174AE

Q26750850-3EA3A706-3676-48E0-B725-7D3FA64C3E97

Q26750850-64D91DD8-827F-4377-AE1E-C31F172B51DE

Q26750850-B7A24EA7-B390-4DCE-9510-4B73A1BC25B2

Q26750850-BBA6F5F4-431B-4224-AE37-371561C599D6

Q26750850-CA595EF7-78E2-4DFB-BD54-4460AD17B3F6

Q26750850-EB2CCD8D-2608-4345-8A26-CDAA3B19231E

P275

Q26750850-927ED26F-E619-4F7D-96EA-40AED55BC467

P2860

Q26750850-03284600-6924-4EDA-97F4-E62D305CE05D

Q26750850-032E2352-2D0D-492A-A3C6-5D6F0D062489

Q26750850-04D874F4-1E88-4190-914B-6572CE82DB2E

Q26750850-05C86647-B421-408B-9038-6009E391C484

Q26750850-0608B035-F57E-408F-AF5F-317297F5BF42

Q26750850-0705BE02-066C-446A-801F-239CB91CCC8D

Q26750850-07C80CEC-C07F-49C6-ACDB-BADBA4E01560

Q26750850-07C842F5-4005-4CE6-96C1-A9B3E522F5EC

Q26750850-0BC03629-7B3A-4FCD-B4A6-89D018C2D252

Q26750850-0BCBEF87-30D0-447E-B95A-95F795D85F06

P304

Q26750850-FB99CA7E-0E12-4456-B027-6E3667D4FC19

P31

Q26750850-8C2399D9-990D-4CA4-8198-8D761C2710C5

Q26750850-DEC83C40-9AFC-4962-A679-20D8D0C2E322

P3181

Q26750850-799B0A73-4DFD-419D-8E0E-7039F4040F0D

P356

Q26750850-D4F9B496-223D-482F-9E1A-7E9A16A11C47

P407

Q26750850-31B187F7-DDA8-4022-A4CC-1371C649998F

P433

Q26750850-CC2F0FE3-9DEB-4F46-8BE3-BD54CD679E2E

P478

Q26750850-0D01F95D-986E-4C02-828E-B86A71BB5955

P577

Q26750850-3642F1E5-FA7E-4A86-9899-CA1B9E458EDA

Q26750850-EA369D97-F23A-42B5-88A8-F14B8F9E2E75

P5875

Q26750850-78CED768-A4FA-48CC-A1FC-D0F40AD8190D

P698

Q26750850-92DA5E64-F114-4707-98C2-5396519D36F2

P921

Q26750850-09FBF477-003A-4C4D-BA21-33BABC48FE13

Q26750850-15820FAD-51C7-463D-85AA-46B9D9DB4830

Q26750850-35238875-CF34-4D19-89D9-10F93FB51EAB

Q26750850-8D1BB7FC-111C-46FF-A8D3-057DD605B3CE

Q26750850-A9F489F0-CE5E-4517-9102-0A8BA1E6CA2D

P932

Q26750850-BB77F776-3DD0-4D1F-AA15-7489708E68E8

P3181

P356

P1433

International Journal of Molecular Sciences

P1476

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

@en

P2093

Changming Zhai

http://www.w3.org/2001/XMLSchema#string

Chongyang Ma

http://www.w3.org/2001/XMLSchema#string

Fafeng Cheng

http://www.w3.org/2001/XMLSchema#string

Qingguo Wang

http://www.w3.org/2001/XMLSchema#string

Wenchao Yue

http://www.w3.org/2001/XMLSchema#string

Xueqian Wang

http://www.w3.org/2001/XMLSchema#string

Yajun Lian

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

The pleiotropic effects of erythropoietin in infection and inflammation

Erythropoietin: powerful protection of ischemic and post-ischemic brain

Allostasis and allostatic load: implications for neuropsychopharmacology

How stress influences the immune response

Structure, function, and activation of the erythropoietin receptor

New approaches to antidepressant drug discovery: beyond monoamines

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways

Differential biological activity of disease-associated JAK2 mutants

P304

677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1802870

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/IJMS17050677

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

302061049

http://www.w3.org/2001/XMLSchema#string

P698

27164096

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

mental depression

P932

4881503

http://www.w3.org/2001/XMLSchema#string